![](/img/cover-not-exists.png)
The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays
Ioulietta Erotokritou-Mulligan, Nishan Guha, Michael Stow, E. Eryl Bassett, Christiaan Bartlett, David A. Cowan, Peter H. Sönksen, Richard I.G. HoltVolume:
22
Year:
2012
Language:
english
DOI:
10.1016/j.ghir.2011.12.005
File:
PDF, 444 KB
english, 2012